Journal of Attention Disorders

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow Corrected Article
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGough, J. J.
Right arrow Articles by Moon, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGough, J. J.
Right arrow Articles by Moon, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Attention Disorders, Vol. 9, No. 3, 476-485 (2006)
DOI: 10.1177/1087054705284089

A Randomized, Double-Blind, Placebo-Controlled, Laboratory Classroom Assessment of Methylphenidate Transdermal System in Children With ADHD

James J. McGough

University of California, Los Angeles, Semel Institute for Neuroscience and Human Behavior, jmcgough{at}mednet.ucla.edu

Sharon B. Wigal

University of California, Irvine, Child Development Center

Howard Abikoff

New York University Child Study Center

John M. Turnbow

Texas Tech University Medical School

Kelly Posner

New York State Psychiatric Institute

Eliot Moon

Elite Clinical Trials, Temecula, California

Objective: This study evaluates the efficacy, duration of action, and tolerability of methylphenidate transdermal system (MTS) in children with ADHD. Method: Participants were dose optimized over 5 weeks utilizing patch doses of 10, 16, 20, and 27 mg applied in the morning and worn for 9 hours. Following optimization, 80 participants were randomized to 1 week of MTS or placebo followed by 1 week of the opposite treatment. Laboratory classroom sessions conducted after each randomized week included blinded ratings of attention, behavior, and academic performance. Results: MTS was well tolerated and displayed significant improvement compared with placebo. Improvements were seen at the first postdose time point measured and continued through 12 hours. Conclusions: Treatment with MTS resulted in statistically significant improvements on all efficacy measures. Time course and therapeutic effects of MTS suggest that this novel methylphenidate delivery system is an efficacious once-daily treatment for ADHD.

Key Words: methylphenidate transdermal system • ADHD • laboratory classroom study • stimulant • patch


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Learn. Mem.Home page
E. J. Dommett, E. L. Henderson, M. S. Westwell, and S. A. Greenfield
Methylphenidate amplifies long-term plasticity in the hippocampus via noradrenergic mechanisms
Learn. Mem., August 6, 2008; 15(8): 580 - 586.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Focus, June 1, 2008; 6(3): 401 - 426.
[Abstract] [Full Text] [PDF]